Shagun Singh
Stock Analyst at RBC Capital
(3.34)
# 1,004
Out of 4,975 analysts
224
Total ratings
54.74%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OM Outset Medical | Reiterates: Sector Perform | $22 | $13.81 | +59.30% | 13 | Aug 19, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Outperform | $615 | $468.92 | +31.15% | 16 | Aug 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $112 → $115 | $104.65 | +9.89% | 16 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Outperform | $330 → $350 | $348.80 | +0.34% | 2 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Outperform | $45 → $25 | $12.53 | +99.52% | 3 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $215 → $180 | $82.94 | +117.02% | 6 | Aug 5, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $130 → $135 | $130.69 | +3.30% | 22 | Aug 1, 2025 | |
| PEN Penumbra | Maintains: Outperform | $330 → $325 | $286.30 | +13.52% | 15 | Jul 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $85 → $89 | $79.98 | +11.28% | 22 | Jul 25, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $181 → $185 | $178.10 | +3.87% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.45 | +106.88% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $147 | $132.41 | +11.02% | 14 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $101 | $92.39 | +9.32% | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $120 | $108.22 | +10.89% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $391.48 | +11.12% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $59.63 | +54.30% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $78.31 | +46.85% | 4 | Oct 25, 2024 |
Outset Medical
Aug 19, 2025
Reiterates: Sector Perform
Price Target: $22
Current: $13.81
Upside: +59.30%
Intuitive Surgical
Aug 19, 2025
Reiterates: Outperform
Price Target: $615
Current: $468.92
Upside: +31.15%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $112 → $115
Current: $104.65
Upside: +9.89%
Insulet
Aug 8, 2025
Maintains: Outperform
Price Target: $330 → $350
Current: $348.80
Upside: +0.34%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $12.53
Upside: +99.52%
Inspire Medical Systems
Aug 5, 2025
Maintains: Outperform
Price Target: $215 → $180
Current: $82.94
Upside: +117.02%
Teleflex
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130 → $135
Current: $130.69
Upside: +3.30%
Penumbra
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $286.30
Upside: +13.52%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $85 → $89
Current: $79.98
Upside: +11.28%
Johnson & Johnson
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $178.10
Upside: +3.87%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.45
Upside: +106.88%
Jul 15, 2025
Maintains: Outperform
Price Target: $145 → $147
Current: $132.41
Upside: +11.02%
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $92.39
Upside: +9.32%
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $108.22
Upside: +10.89%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $391.48
Upside: +11.12%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $59.63
Upside: +54.30%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $78.31
Upside: +46.85%